3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Dupuytren Contracture
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Specimen Handling
5
Biopsy
5
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
Azacitidine
3
venetoclax
2
ruxolitinib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Decitabine
2
Busulfan
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
iadademstat
1
gilteritinib
1
fludarabine
1
fedratinib
1
axatilimab
1
Tranexamic Acid
1
Topotecan
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.